InvestorsHub Logo
Followers 2
Posts 79
Boards Moderated 0
Alias Born 06/23/2014

Re: None

Thursday, 08/14/2014 2:52:14 PM

Thursday, August 14, 2014 2:52:14 PM

Post# of 80490
BCR-ABL1 Compound Mutations Combining Key Kinase Domain Positions Confer Clinical Resistance to Ponatinib in Ph Chromosome-Positive Leukemia

Available online 14 August 2014


source: Cancer Cell

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.